We found that cyclin E1 is stabilized in BRCA1 mutated breast tumors in association with reduced phosphorylation on cyclin E1 Threonine 62, and high cyclin E1 is associated with decreased overall survival for patients with BRCA1 mutation. The gene discussed is BRCA1; the disease is breast neoplasm.